Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Homeland Security Advisory Council

Executive Summary

Lilly CEO Sidney Taurel named to President Bush's Homeland Security Advisory Council created by executive order March 19...

You may also be interested in...

Lilly’s “shared sense of values”

Lilly CEO Sidney Taurel tells Aug. 29 meeting of President's Homeland Security Advisory Council that running a successful organization requires the creation of "a common culture" resulting from "a sense of shared values." The meeting focused on advice to the Administration on creating a new Homeland Security Department; it featured presentations from corporate executives on strategies for successful integration after mergers. Taurel, from the steadfastly independent Lilly, was appointed to the council in June (1"The Pink Sheet" June 17, In Brief)...

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts